These trials, combined with many mechanism of action studies and numerous Questcor-sponsored investigator initiated studies, are aimed at building the body of evidence surrounding the safety and efficacy of Acthar
in both on-label and potential new indications.
is contraindicated where congenital infections are suspected in infants.
Gel is likely to be a strong complement to Mallinckrodt's portfolio of specialty pharmaceutical brands.
is increasingly being employed by specialty physicians in the treatment of a range of serious, difficult-to-treat autoimmune and inflammatory conditions, where patients often have exhausted other good therapeutic options.
Gel that is used to treat certain disorders with an inflammatory component.
"), an injectable drug approved by the U.
Gel (repository corticotropin injection) will be presented at the American College of Rheumatology (ACR) 2015 Annual Meeting to be held November 7-11 in San Francisco.
With this purchase, Questcor Pharmaceuticals aims to protect the manufacturing process trade secrets about Acthar
Specifically, defendants misrepresented and/or failed to disclose that: (i) the Company was disseminating false and misleading statements to the public concerning the efficacy of Acthar
as a treatment for multiple sclerosis and for nephrotic syndrome; (ii) the Company was marketing and promoting Acthar
aggressively as a treatment for these conditions, with an inadequate compliance program; and (iii) as a result of the above, the Company's financial statements were materially false and misleading at all relevant times.
Furie will share the first results of our pilot study on the effects of Acthar
in patients with this challenging disease at the upcoming ACR Annual Meeting," saidSteven Romano, M.
Gel will move forward to function in Prince Edward Island, Canada, in its existing management team with Questcor's support.
Gel, an injectable drug for the treatment of acute exacerbations of multiple sclerosis in adults.